Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$2,136,016
-$328,340 QoQ
Shares Held
88,705
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#927
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEARLE & CO. holds $43,484,840 across 9 Drug Manufacturers - General names. PFE ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
49,202 | $12,381,191 | |
| 2 | JNJ |
Johnson & Johnson
|
39,252 | $9,968,830 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,913 | $7,056,320 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
79,700 | $4,592,314 | |
| 5 | LLY |
ELI LILLY & Co
|
3,530 | $4,233,988 | |
| 6 | AMGN |
Amgen Inc
|
6,771 | $2,451,914 | |
| 7 | PFE |
Pfizer Inc
This page
|
88,705 | $2,136,016 | |
| 8 | SNY |
Sanofi
|
9,500 | $405,270 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,136,016 | 88,705 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,464,356 | 87,762 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,251,433 | 90,419 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,346,962 | 92,110 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,249,932 | 92,819 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,396,378 | 94,569 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,577,654 | 97,160 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,693,416 | 93,069 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $3,125,282 | 111,697 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,397,018 | 50,343 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,650,904 | 57,343 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,713,704 | 81,812 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $3,046,860 | 83,066 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,450,129 | 84,562 | Shares | Sole | 2023-06-01 | |
| 2022-12-31 | $4,414,940 | 86,162 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $3,770,449 | 86,162 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,517,473 | 86,162 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $4,460,606 | 86,162 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,987,481 | 84,462 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $3,475,767 | 80,813 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $3,145,057 | 80,313 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $3,235,809 | 89,313 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,956,321 | 80,313 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,969,504 | 80,913 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,833,883 | 86,663 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $2,832,462 | 86,779 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||